Scott Milligan

1.5k total citations
58 papers, 1.1k citations indexed

About

Scott Milligan is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Scott Milligan has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hepatology, 16 papers in Epidemiology and 11 papers in Rheumatology. Recurrent topics in Scott Milligan's work include Hepatitis C virus research (28 papers), Systemic Lupus Erythematosus Research (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Scott Milligan is often cited by papers focused on Hepatitis C virus research (28 papers), Systemic Lupus Erythematosus Research (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Scott Milligan collaborates with scholars based in United States, United Kingdom and Switzerland. Scott Milligan's co-authors include Zobair M. Younossi, David R. Hyde, Joseph E. O’Tousa, Mark Goebl, Nezam H. Afdhal, Vytas A. Bankaitis, James G. Alb, Steven L. Flamm, Bruce R. Bacon and Michelle Lai and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Scott Milligan

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Milligan United States 15 377 332 289 270 103 58 1.1k
Stephan Schlösser Germany 17 503 1.3× 260 0.8× 119 0.4× 82 0.3× 57 0.6× 18 1.3k
Sadahiko Iwamoto Japan 22 355 0.9× 278 0.8× 70 0.2× 109 0.4× 20 0.2× 81 1.6k
Eyvind J. Paulssen Norway 19 271 0.7× 194 0.6× 65 0.2× 24 0.1× 69 0.7× 46 886
Stephen J. Usala United States 22 713 1.9× 204 0.6× 117 0.4× 56 0.2× 54 0.5× 50 2.2k
Carrie S. Dolman United States 17 393 1.0× 410 1.2× 71 0.2× 80 0.3× 44 0.4× 21 1.4k
Jianli Dai China 18 462 1.2× 121 0.4× 11 0.0× 215 0.8× 74 0.7× 27 958
Jennifer Doyle United States 11 489 1.3× 83 0.3× 20 0.1× 126 0.5× 28 0.3× 30 817
S. Saito Japan 21 280 0.7× 92 0.3× 39 0.1× 20 0.1× 243 2.4× 51 1.4k
Mustafa Pehlıvan Türkiye 17 219 0.6× 82 0.2× 27 0.1× 38 0.1× 28 0.3× 117 867

Countries citing papers authored by Scott Milligan

Since Specialization
Citations

This map shows the geographic impact of Scott Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Milligan more than expected).

Fields of papers citing papers by Scott Milligan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Milligan. The network helps show where Scott Milligan may publish in the future.

Co-authorship network of co-authors of Scott Milligan

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Milligan. A scholar is included among the top collaborators of Scott Milligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Milligan. Scott Milligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Connor, Maeve, et al.. (2025). Study to Adjudicate Hereditary Angioedema with Normal C1INH Diagnoses in the PIONEER-HAE Database. Journal of Allergy and Clinical Immunology. 155(2). AB432–AB432.
2.
Farber, Harrison W., Murali M. Chakinala, Michelle Cho, et al.. (2023). Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository. Pulmonary Circulation. 13(3). e12258–e12258. 3 indexed citations
3.
Worley, Karen, Scott Milligan, & Bernard Rubin. (2023). Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data. Lupus Science & Medicine. 10(2). e001024–e001024. 5 indexed citations
4.
Helfgott, Simon M., et al.. (2023). AB1824-HPR MULTIPLE TNFI TREATMENT CYCLES AND THE FAILURE OF TRIAL-AND-ERROR CARE FOR PATIENTS WITH RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 82. 2144–2144. 1 indexed citations
5.
Milligan, Scott, et al.. (2021). Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD. Hepatology Communications. 6(4). 765–779. 58 indexed citations
6.
Curry, Michael P., Steven L. Flamm, Scott Milligan, et al.. (2021). Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study. Journal of Managed Care & Specialty Pharmacy. 27(9). 1239–1248. 6 indexed citations
7.
Reddy, K. Rajender, Michael P. Curry, Ho Bae, et al.. (2020). Longer-term experience with tenofovir alafenamide (TAF) in HBV-infected patients; changes in EGFR, FIB4, ALT, and DNA suppression. Journal of Hepatology. 73. S881–S882. 4 indexed citations
8.
Curry, Michael P., Ho Bae, Douglas T. Dieterich, et al.. (2020). Differential tenofovir alafenamide (TAF) adoption in HBV-infected populations; assessment of care in US clinical practice. Journal of Hepatology. 73. S876–S876. 2 indexed citations
9.
Curry, Michael P., Douglas T. Dieterich, Victor Ankoma‐Sey, et al.. (2019). PIN9 CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF HEPATITIS B IN THE US. Value in Health. 22. S196–S196.
10.
Flamm, Steven L., Bruce R. Bacon, Michael P. Curry, et al.. (2018). Real‐world use of elbasvir‐grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network. Alimentary Pharmacology & Therapeutics. 47(11). 1511–1522. 23 indexed citations
11.
O’Leary, Aisling, et al.. (2018). The impact of individual patient data in a network meta‐analysis: An investigation into parameter estimation and model selection. Research Synthesis Methods. 9(3). 441–469. 12 indexed citations
12.
Curry, Michael P., Elliot B. Tapper, Bruce R. Bacon, et al.. (2017). Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients. Alimentary Pharmacology & Therapeutics. 46(5). 540–548. 30 indexed citations
13.
Milligan, Scott, et al.. (2013). Third-Party Validation of Observed Savings From an Oncology Pathways Program. The American Journal of Managed Care. 19. 3 indexed citations
14.
Erridge, Clett, Anne Burdess, Clare Murray, et al.. (2008). Vascular cell responsiveness to Toll‐like receptor ligands in carotid atheroma. European Journal of Clinical Investigation. 38(10). 713–720. 51 indexed citations
15.
Parker, Malcolm G., R White, Göran Leonardsson, Scott Milligan, & Jennifer H. Steel. (2004). Identification of RIP140 as a Nuclear Receptor Cofactor with a Role in Female Reproduction. PubMed. 23–31. 1 indexed citations
16.
Fraser, Nia, et al.. (2002). Handlebar hernia masquerading as an inguinal haematoma. Hernia. 6(1). 39–41. 29 indexed citations
17.
Cassidy, Aedín & Scott Milligan. (1998). How significant are environmental estrogens to women?. Climacteric. 1(3). 229–242. 14 indexed citations
18.
Chang, Jinghua Tsai, Scott Milligan, Yuanyuan Li, et al.. (1997). Mammalian homolog of Drosophila retinal degeneration B rescues the mutant fly phenotype.. PubMed. 17(15). 5881–90. 58 indexed citations
19.
Dickman, R. L., Amasa B. Ford, Jon C. Liebman, Scott Milligan, & Alvin L. Schorr. (1987). An End to Patchwork Reform of Health Care. New England Journal of Medicine. 317(17). 1086–1089. 12 indexed citations
20.
Milligan, Scott, et al.. (1986). Growth retardation: why are pygmies small?. PubMed. 82(15). 42–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephan Schlösser Breakdown of academic impact, for papers by Sadahiko Iwamoto Breakdown of academic impact, for papers by Eyvind J. Paulssen Breakdown of academic impact, for papers by Stephen J. Usala Breakdown of academic impact, for papers by Carrie S. Dolman Breakdown of academic impact, for papers by Jianli Dai Breakdown of academic impact, for papers by Jennifer Doyle Breakdown of academic impact, for papers by S. Saito Breakdown of academic impact, for papers by Mustafa Pehlıvan
Rankless by CCL
2026